(However,,2.8701690505786455)
(associated,2.8701690505786455)
(cancer,,2.8701690505786455)
(imaging,2.505525936990736)
(rapidly,2.3513752571634776)
((VEGFA,,2.3513752571634776)
((EF),,2.3513752571634776)
(techniques,2.3513752571634776)
(Observational,2.3513752571634776)
(ondata,2.3513752571634776)
(BC,2.3513752571634776)
(algorithm,2.3513752571634776)
(special,2.3513752571634776)
(harmless,2.3513752571634776)
(0.015).,2.3513752571634776)
(side,2.3513752571634776)
(50.,2.3513752571634776)
(concerns,2.3513752571634776)
(assessment,2.3513752571634776)
(requiring,2.3513752571634776)
(Similar,2.3513752571634776)
(include,2.3513752571634776)
(flow,2.3513752571634776)
(palliative,2.3513752571634776)
(concept,2.3513752571634776)
(Extra-Terminal,2.3513752571634776)
(suggesting,2.3513752571634776)
(generated,2.3513752571634776)
(prescriptions,2.3513752571634776)
(immunohistochemistry,2.3513752571634776)
(<,2.3513752571634776)
(NAC.,2.3513752571634776)
(improve,2.3513752571634776)
(3,2.3513752571634776)
(intrauterine,2.3513752571634776)
(LEVEL,2.3513752571634776)
(Breast,,2.3513752571634776)
(molecule,2.3513752571634776)
(population.,2.3513752571634776)
(inhibitory,2.3513752571634776)
(high-dose,2.3513752571634776)
(Bromodomain,2.3513752571634776)
(Because,2.3513752571634776)
(01.01.2010,2.3513752571634776)
(editing,2.3513752571634776)
(acute,2.3513752571634776)
(copyright.,2.3513752571634776)
(agents,,2.3513752571634776)
(allowed,2.3513752571634776)
(algorithm.,2.3513752571634776)
(IMAGING,2.3513752571634776)
(properly,2.3513752571634776)
(increment,2.3513752571634776)
(People,2.3513752571634776)
(drains,2.3513752571634776)
(micelles.,2.3513752571634776)
(36,2.3513752571634776)
(confirmation,2.3513752571634776)
(predictive,2.3513752571634776)
(greater,2.3513752571634776)
(met,2.3513752571634776)
(remained,2.3513752571634776)
(imagesneed,2.3513752571634776)
(Both,2.3513752571634776)
(syndromes.,2.3513752571634776)
(moist,2.3513752571634776)
(46.0,2.3513752571634776)
(Unfortunately,2.3513752571634776)
(substantial,2.3513752571634776)
(consultations.,2.3513752571634776)
(simplify,2.3513752571634776)
(Better,2.3513752571634776)
(considering,2.3513752571634776)
(motivation,2.3513752571634776)
(14,2.3513752571634776)
(refractory,2.3513752571634776)
(stratified,2.3513752571634776)
(HER2,,2.3513752571634776)
(evaluated,2.3513752571634776)
(non-ideal,,2.3513752571634776)
(b-cryptoxanthin,,2.3513752571634776)
(alternative,2.3513752571634776)
(routinely,2.3513752571634776)
(excision,2.3513752571634776)
(ion,2.3513752571634776)
(values,2.3513752571634776)
(personalistic,2.3513752571634776)
(purposively,2.3513752571634776)
((8,2.3513752571634776)
(literature.,2.3513752571634776)
(States,2.3513752571634776)
(checkpoint,2.3513752571634776)
(comprehensive,2.3513752571634776)
((NFPA),2.3513752571634776)
(Information,2.3513752571634776)
(system,number,2.3513752571634776)
(optoacoustic,2.3513752571634776)
(formation,2.3513752571634776)
(generally,2.3513752571634776)
(regional,2.3513752571634776)
(clustering,2.3513752571634776)
(intra-operative,2.3513752571634776)
(model,,2.3513752571634776)
(0.70,2.3513752571634776)
(result,,2.3513752571634776)
(images.,2.3513752571634776)
(radiologists,,2.3513752571634776)
(accumulation.,2.3513752571634776)
(dynamic,2.3513752571634776)
(Negative,2.3513752571634776)
(choice,2.3513752571634776)
(total,2.3513752571634776)
(avoid,2.3513752571634776)
(trials,2.3513752571634776)
(yielded,2.3513752571634776)
(utilized,2.3513752571634776)
(errors,2.3513752571634776)
(exploit,2.3513752571634776)
(recorded.,2.3513752571634776)
(microRNA,2.3513752571634776)
(towavelet,2.3513752571634776)
(93.45%,2.3513752571634776)
((NST),2.3513752571634776)
(contours.,2.3513752571634776)
(mammography,,2.3513752571634776)
(January,2.3513752571634776)
(status,,2.3513752571634776)
(clearly,2.3513752571634776)
(tomosynthesis,,2.3513752571634776)
(BMI,2.3513752571634776)
(Forty-two,2.3513752571634776)
(DEM,,2.3513752571634776)
(a-carotene,,2.3513752571634776)
(Guided,2.3513752571634776)
(focusing,2.3513752571634776)
(causation,2.3513752571634776)
(study.,2.3513752571634776)
(shared,2.3513752571634776)
(cancers.,2.3513752571634776)
(23,2.3513752571634776)
(larger,2.3513752571634776)
(J.,2.3513752571634776)
(summarize,2.3513752571634776)
(lower,2.3513752571634776)
(misdiagnosis,2.3513752571634776)
(transtuzumab.,2.3513752571634776)
(validated,2.3513752571634776)
(results.,2.3513752571634776)
(proportion,2.3513752571634776)
(negligible,2.3513752571634776)
(adjuvant,2.3513752571634776)
(interpretation,2.3513752571634776)
(Osteopontin-750,2.3513752571634776)
(atechnique,2.3513752571634776)
(intensity,2.3513752571634776)
((TNBC),2.3513752571634776)
(1062,2.3513752571634776)
(diagnoses,2.3513752571634776)
(study;,2.3513752571634776)
(investigate,2.3513752571634776)
(38.7%),2.3513752571634776)
(theory,2.3513752571634776)
(Diagnostic,2.3513752571634776)
(An,2.3513752571634776)
(update,2.3513752571634776)
(fraction.,2.3513752571634776)
(broader,2.3513752571634776)
(At,2.3513752571634776)
(MCL-1,2.3513752571634776)
(filters,2.3513752571634776)
(offer,2.3513752571634776)
(demographics,,2.3513752571634776)
(estradiol,2.3513752571634776)
(Multivariate,2.3513752571634776)
(cost,2.3513752571634776)
(precision,2.3513752571634776)
(decades,2.3513752571634776)
(oxide,2.3513752571634776)
(respectively.,2.3513752571634776)
(Given,2.3513752571634776)
(OS,,2.3513752571634776)
(detectionof,2.3513752571634776)
(clinic,2.3513752571634776)
(phantom,2.3513752571634776)
(Notably,,2.3513752571634776)
(hormone,2.3513752571634776)
(All,2.3513752571634776)
(segmentation,2.3513752571634776)
(1,444,2.3513752571634776)
(HER4),,2.3513752571634776)
(VEGFC,,2.3513752571634776)
(crucial,2.3513752571634776)
(difficult,2.3513752571634776)
(17,2.3513752571634776)
((DEM),,2.3513752571634776)
(cancercells,2.3513752571634776)
((NPV).,2.3513752571634776)
(network,2.3513752571634776)
(HER3,2.3513752571634776)
(kg/m2.,2.3513752571634776)
(pattern,2.3513752571634776)
(modified,2.3513752571634776)
(applicable,2.3513752571634776)
(prolactinomas,,2.3513752571634776)
(1996,2.3513752571634776)
(31.12.2014,2.3513752571634776)
(So,2.3513752571634776)
(inception,2.3513752571634776)
(Cardiac,2.3513752571634776)
(noncoding,2.3513752571634776)
(computed,2.3513752571634776)
(mortality,2.3513752571634776)
((Ag2S-NP),,2.3513752571634776)
(Anthracyclines,2.3513752571634776)
((PR),,2.3513752571634776)
(a.u.,2.3513752571634776)
(wider,2.3513752571634776)
(administration,2.3513752571634776)
(scan,2.3513752571634776)
(typical,2.3513752571634776)
(normal,2.3513752571634776)
(cardiotoxicities,2.3513752571634776)
(occurred,2.3513752571634776)
(stratification,,2.3513752571634776)
(VEGFB,,2.3513752571634776)
(discovered,2.3513752571634776)
(human.,2.3513752571634776)
(PET/CT,2.3513752571634776)
(defined,2.3513752571634776)
(Anti-HER2,2.3513752571634776)
(maintaining,2.3513752571634776)
(implemented,2.3513752571634776)
(intrinsic,2.3513752571634776)
(number,2.3513752571634776)
(detected,2.3513752571634776)
(gadolinium-based,2.3513752571634776)
(RAD51,2.3513752571634776)
(III,2.3513752571634776)
(disproportionate,2.3513752571634776)
((10.0%),2.3513752571634776)
(reviewed,2.3513752571634776)
(9.7,2.3513752571634776)
(Conventional,2.3513752571634776)
(course,2.3513752571634776)
(finding,2.3513752571634776)
(stratification,2.3513752571634776)
(mutational,2.3513752571634776)
(2005-2017.,2.3513752571634776)
(Filipino,2.3513752571634776)
(7/18,2.3513752571634776)
(designed,2.3513752571634776)
(apparent,2.3513752571634776)
(radiology,2.3513752571634776)
(581,2.3513752571634776)
(subjective,2.3513752571634776)
(wound,2.3513752571634776)
(1200,2.3513752571634776)
(fee-for-service,2.3513752571634776)
(formulation,2.3513752571634776)
(CDDP),2.3513752571634776)
((P,2.3513752571634776)
(body,2.3513752571634776)
(identified,,2.3513752571634776)
(production.,2.3513752571634776)
((DWI),2.3513752571634776)
(vivo,,2.3513752571634776)
((eg,,2.3513752571634776)
(conventional,2.3513752571634776)
(Selective,2.3513752571634776)
(effects.,2.3513752571634776)
(protected,2.3513752571634776)
(general,2.3513752571634776)
(tend,2.3513752571634776)
(physical,2.3513752571634776)
(Efficacy:,2.3513752571634776)
(adjustment,2.3513752571634776)
(35,2.3513752571634776)
(medicine,2.3513752571634776)
(0.50-0.99;,2.3513752571634776)
(evidenced,2.3513752571634776)
(vitro,2.3513752571634776)
(highest,2.3513752571634776)
(PI3K/Akt/mTOR,2.3513752571634776)
(Altogether,,2.3513752571634776)
(scrutiny,2.3513752571634776)
(initial,2.3513752571634776)
(intervention,2.3513752571634776)
(adoption,2.3513752571634776)
(grade,,2.3513752571634776)
(MEK,2.3513752571634776)
(rising,2.3513752571634776)
(counseling,2.3513752571634776)
(index,,2.3513752571634776)
(year.,2.3513752571634776)
(Group,2.3513752571634776)
(set,,2.3513752571634776)
(implemented.,2.3513752571634776)
(agent.,2.3513752571634776)
(asymptomatic,2.3513752571634776)
(self-examination.,2.3513752571634776)
(monitoring,2.3513752571634776)
(will,2.3513752571634776)
((CIs),2.3513752571634776)
(analyzing,2.3513752571634776)
((43.6,2.3513752571634776)
(studies),,2.3513752571634776)
(carcinogenesis,2.3513752571634776)
(agreement,2.3513752571634776)
(system-both,2.3513752571634776)
(prolactinomas,2.3513752571634776)
(criteria.,2.3513752571634776)
(hinder,2.3513752571634776)
(chemotherapy.,2.3513752571634776)
(evaluation,2.3513752571634776)
(test,2.3513752571634776)
(paradigm,2.3513752571634776)
(Interestingly,,2.3513752571634776)
(meta-analysis,2.3513752571634776)
(resonance,2.3513752571634776)
(Tumour,2.3513752571634776)
(vulnerability.,2.3513752571634776)
(barriers,2.3513752571634776)
(death,,2.3513752571634776)
(ml).,2.3513752571634776)
(latest,2.3513752571634776)
(without.,2.3513752571634776)
(Aims,2.3513752571634776)
(mice,2.3513752571634776)
(term,,2.3513752571634776)
(intravenous,2.3513752571634776)
(breasts.,2.3513752571634776)
(similar.,2.3513752571634776)
(RESON.,2.3513752571634776)
(monoclonal,2.3513752571634776)
(Colorectal,2.3513752571634776)
(pursue,2.3513752571634776)
(recombination,2.3513752571634776)
(required,2.3513752571634776)
(Fatigue.In,2.3513752571634776)
(applications,,2.3513752571634776)
(2016.,2.3513752571634776)
(subcutaneous,2.3513752571634776)
(Nine,2.3513752571634776)
(reserved,2.3513752571634776)
(proportional,2.3513752571634776)
(Meta-regression,2.3513752571634776)
(Conclusions:,2.3513752571634776)
(3.0).,2.3513752571634776)
(rapid,2.3513752571634776)
(breast,,2.3513752571634776)
(preclinical,2.3513752571634776)
(fluorescence,2.3513752571634776)
((BET),2.3513752571634776)
(spite,2.3513752571634776)
(calculate,2.3513752571634776)
(components,,2.3513752571634776)
(screening.,2.3513752571634776)
(lag.,2.3513752571634776)
(tumour-related,2.3513752571634776)
(0.75-1.09).,2.3513752571634776)
(ultrasound.,2.3513752571634776)
(trastuzumab.,2.3513752571634776)
(discomfort.,2.3513752571634776)
(combination,,2.3513752571634776)
(continuing,2.3513752571634776)
(induction,2.3513752571634776)
(52,723,2.3513752571634776)
(relative,2.3513752571634776)
(underwent,2.3513752571634776)
(preliminary,2.3513752571634776)
(symptom,2.3513752571634776)
(classify,2.3513752571634776)
(5.8%,,2.3513752571634776)
(literature,2.3513752571634776)
(clinic.,2.3513752571634776)
(Technical,2.3513752571634776)
(spectrometry.,2.3513752571634776)
(AND,2.3513752571634776)
(15.3%,2.3513752571634776)
(8/18,2.3513752571634776)
((mastectomy,2.3513752571634776)
(appealing,,2.3513752571634776)
(500,000,2.3513752571634776)
(lycopene,,2.3513752571634776)
(frequently,2.3513752571634776)
((44%),2.3513752571634776)
(far,,2.3513752571634776)
(variable,2.3513752571634776)
(trastuzumab-induced,2.3513752571634776)
(developments,2.3513752571634776)
(PubMed,2.3513752571634776)
(examination.,2.3513752571634776)
(0.049).,2.3513752571634776)
(accuracy,2.3513752571634776)
(apoptosis,2.3513752571634776)
(causes,,2.3513752571634776)
(corresponding,2.3513752571634776)
(classifier.,2.3513752571634776)
(inconsistent,2.3513752571634776)
(prediagnosis,2.3513752571634776)
